Clas-Göran af Björkesten

Metabolic Syndrome in Type 1 Diabetes

Lena M. Thorn, Carol Forsblom, Johan Fagerudd et al. · Diabetes Care · 2005 · 428 citations · Full text

Medicine, Endocrinology, Internal Medicine +13

Fecal calprotectin concentration predicts outcome in inflammatory bowel disease after induction therapy with TNFα blocking agents

Pauliina Molander, Clas-Göran af Björkesten, Harri Mustonen et al. · Inflammatory Bowel Diseases · 2012 · 170 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease

Clas-Göran af Björkesten, Urpo Nieminen, Ulla Turunen et al. · Scandinavian Journal of Gastroenterology · 2012 · 154 citations

Medicine, Clinical Sciences, Immunology +17

Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment

Taina Sipponen, Clas-Göran af Björkesten, Martti Färkkilâ et al. · Scandinavian Journal of Gastroenterology · 2009 · 153 citations

Medicine, Clinical Sciences, Internal Medicine +17

Early autonomic dysfunction in type 1 diabetes: a reversible disorder?

Milla Rosengård‐Bärlund, Luciano Bernardi, J. Fagerudd et al. · Diabetologia · 2009 · 83 citations · Full text

Medicine, Endocrinology, Internal Medicine +12